<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02132364</url>
  </required_header>
  <id_info>
    <org_study_id>2011_34</org_study_id>
    <secondary_id>2012-A00473-40</secondary_id>
    <secondary_id>PHRIP 2012 - NÂ°12-019-0306</secondary_id>
    <nct_id>NCT02132364</nct_id>
  </id_info>
  <brief_title>Controlled Education Of Patients After Stroke</brief_title>
  <acronym>CEOPS</acronym>
  <official_title>Controlled Education Of Patients After Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the study is to compare the benefit of optimised follow-up by nursing
      personnel from the vascular neurology department, including therapeutic follow-up and an
      educational program directed to the patient and a caregiving member of his social circle,
      with that of a typical follow-up.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 30, 2014</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>blood pressure</measure>
    <time_frame>12 months</time_frame>
    <description>blood pressure will be measured by nursing personnel who do not know the group into which the patient has been randomised.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Outcome of stroke</measure>
    <time_frame>6 months 12 months 2 years.</time_frame>
    <description>functional handicap (Rankin scale) cognitive state (MoCA scale)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Stroke</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>optimised follow-up</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>optimised follow-up will be done by nursing personnel associated with a caregiving member of his social circle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>typical follow-up</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>optimised follow-up</intervention_name>
    <description>optimised follow-up will be done by nursing personnel associated with a caregiving member of his social circle.</description>
    <arm_group_label>optimised follow-up</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over 60 years of age

          -  Patients who have had a first stroke, transient or permanent, ischaemic or
             haemorrhagic, justifying hospitalisation

          -  Patients with high blood pressure already treated or discovered at the time of the
             stroke and justifying the start of a treatment

          -  Patients who have had a stroke with sequelae allowing immediate return home or
             justifying a stay of less than one month in rehabilitation

          -  Patient having a member of his social circle who has agreed to provide follow-up for
             two years in association with the assigned nursing personnel in case of randomisation
             into the &quot;optimised follow-up&quot; group.

        Exclusion criteria

          -  Patients less than 60 years of age

          -  Patients with a history of stroke

          -  Patients who do not have high blood pressure discovered by a treatment prior to the
             stroke or by abnormal blood pressure figures during hospitalisation

          -  Patients who have had a stroke causing serious sequelae, justifying an extended stay
             in a rehabilitation department

          -  Patient who has no one in his social circle capable of working with the assigned
             nursing personnel, or patient living in an institution
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>REGIS BORDET, MD phD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Regis BORDET, MD phD</last_name>
    <phone>+33 (0)3 20 44 54 49</phone>
    <email>regis.bordet@univ-lille2.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Besancon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>THIERRY MOULIN, MDphD</last_name>
      <phone>+33 (0)3 01 66 84 38</phone>
      <email>thierry.moulin@univ-fcomte.fr</email>
    </contact>
    <investigator>
      <last_name>THIERRY MOULIN, MD phD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>IGOR SIBON, MD phD</last_name>
      <phone>+33(0)5 79 55 20</phone>
      <email>igor.sibon@chu-bordeaux.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH</name>
      <address>
        <city>Calais</city>
        <zip>62100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>OLIVIER DEREEPER, MD</last_name>
      <phone>+33 (0)3 21 46 33 33</phone>
      <email>o.dereeper@ch-calais.fr</email>
    </contact>
    <investigator>
      <last_name>OLIVIER DEREEPER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MAURICE GIROUD, MD phD</last_name>
      <phone>+33 (0)3 03 80 29 37 53</phone>
      <email>maurice.giroud@chu-dijon.fr</email>
    </contact>
    <investigator>
      <last_name>MAURICE GIROUD, MD phD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>REGIS BORDET, MD phD</last_name>
      <phone>+33 (0)3 20 44 54 49</phone>
      <email>regis.bordet@univ-lille2.fr</email>
    </contact>
    <investigator>
      <last_name>REGIS BORDET, MDphD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>DIDIER LEYS, MD phdD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ch Saint Joseph</name>
      <address>
        <city>Paris</city>
        <zip>75674</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>MATHIEU ZUBER, MD phd</last_name>
      <phone>+33 (0)1 44 12 34 09</phone>
      <email>m.zuber@hpsj.fr</email>
    </contact>
    <investigator>
      <last_name>MATHIEU ZUBER, MD phD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>EVELYNE MASSARDIER, MD</last_name>
      <phone>+33 (0)2 32 88 87 40</phone>
      <email>evelyne.massadier@chu-rouen.fr</email>
    </contact>
    <investigator>
      <last_name>EVELYNE MASSARDIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>AUDE TRIQUENOT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 5, 2014</study_first_submitted>
  <study_first_submitted_qc>May 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2014</study_first_posted>
  <last_update_submitted>April 23, 2018</last_update_submitted>
  <last_update_submitted_qc>April 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>hypertension</keyword>
  <keyword>secondary prevention</keyword>
  <keyword>educational program</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

